Nu Skin Enterprises (NYSE:NUS) Issues Earnings Results

Nu Skin Enterprises (NYSE:NUS) posted its earnings results on Thursday. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.11), FiscalAI reports. Nu Skin Enterprises had a positive return on equity of 6.58% and a negative net margin of 15.73%. The business had revenue of $311.01 million during the quarter, compared to analysts’ expectations of $328.70 million.

Here are the key takeaways from Nu Skin Enterprises’ conference call:

• Nu Skin reported Q3 revenue of $311 million and adjusted EPS of $0.10, both within guidance. For the full year, it expects revenue of $1.26 billion–$1.29 billion and adjusted EPS of $0.55–$0.65.
• Profitability weakened: gross margin fell to 65% from 70.5% a year earlier, largely due to business mix, while adjusted operating margin declined to 3.7% from 5.9%. The company said customer and sales metrics in its core business remain under pressure.
• Prysm iO had approximately 41,000 devices placed and 4.5 million scans through Q3; after its app update, scan-to-purchase conversion more than doubled to 10%. LifePak sales also grew nearly 3% year to date.
• Nu Skin is investing in sales-channel training and development as it works to rebuild affiliate engagement and productivity, but management acknowledged that overall customer and sales metrics remain pressured.
• Rhyz, Nu Skin’s manufacturing platform, delivered strong year-over-year revenue growth. Management also expects its East-West operating model and regional manufacturing hubs to improve efficiency and profitability over time, though those benefits are still ahead.

Nu Skin Enterprises Price Performance

Shares of NUS traded down $0.43 during mid-day trading on Friday, reaching $4.09. 896,360 shares of the stock traded hands, compared to its average volume of 438,449. The company has a market cap of $199.34 million, a price-to-earnings ratio of -0.85 and a beta of 0.92. Nu Skin Enterprises has a 1 year low of $4.09 and a 1 year high of $11.67. The firm has a fifty day moving average price of $4.75 and a 200 day moving average price of $6.27. The company has a current ratio of 1.98, a quick ratio of 1.24 and a debt-to-equity ratio of 0.36.

Nu Skin Enterprises Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 9th. Stockholders of record on Friday, November 27th will be given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date is Friday, November 27th. Nu Skin Enterprises’s payout ratio is -5.37%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on NUS. Zacks Research raised shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a report on Monday, October 12th. Weiss Ratings cut shares of Nu Skin Enterprises from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Reduce”.

Key Stories Impacting Nu Skin Enterprises

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Nu Skin declared a quarterly dividend of $0.06 per share, payable December 9 to shareholders of record November 27. The annualized payout is $0.24 per share. Nu Skin Enterprises company information
• Neutral Sentiment: Management’s 2026 revenue guidance of $1.3 billion was in line with consensus, though it does not imply a near-term recovery in sales. Nu Skin reports third-quarter earnings
• Negative Sentiment: Third-quarter results missed estimates: revenue was $311.0 million versus $328.7 million expected, and adjusted EPS was $0.10 versus the $0.21 consensus. Revenue fell 14.6% year over year; customers, paid affiliates, and sales leaders also declined. Nu Skin Q3 earnings and revenues lag estimates
• Negative Sentiment: Nu Skin forecast 2026 EPS of $0.55–$0.65, below the $0.82 consensus estimate, signaling lower expected profitability. The company reported a GAAP loss of $0.02 per share for the quarter, compared with $0.34 EPS a year earlier. Nu Skin reports third-quarter earnings

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a global direct-selling company that develops and distributes personal care and wellness products. Its portfolio includes skincare, beauty and personal care products, nutritional supplements, and wellness-related devices and technologies. The company markets products under brands including Nu Skin and Pharmanex, with its ageLOC product line focused on skincare and age-related wellness.

Founded in 1984 and headquartered in Provo, Utah, Nu Skin sells its products primarily through a network of independent distributors, supported by digital commerce and other direct-to-consumer channels.